Nexalin trials Halo neurostimulation device in traumatic brain injury

Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the company’s neurostimulation device, Gen-3 Halo headset,...

SeaStar hits halfway mark in AKI trial for selective cytopheretic device

SeaStar Medical has announced a significant milestone in its pivotal NEUTRALIZE-AKI trial with 51 subjects enrolled, surpassing the halfway point toward its target of...

Endospan completes enrolment in aortic arch stent graft study

Endospan completed enrolment for the primary arm of its TRIOMPHE FDA investigational device exemption (IDE) trial. TRIOMPHE evaluates the safety and efficacy of the...

Microbot Medical completes trial, set to submit surgical robot to FDA this year

Microbot Medical successfully completed enrolment and follow-up in its surgical robot clinical trial. The Braintree, Massachusetts–based company completed enrolment and follow-up for all patients...

Rivanna starts trial for AI-enabled Accuro XV imaging system

Virginia-based Rivanna has initiated a feasibility study evaluating its artificial intelligence (AI) enabled Accuro XV musculoskeletal imaging system. The study will enrol 200 patients to...

4C Medical commences enrolment in heart valve trial

4C Medical Technologies commenced enrolment in its ATLAS pivotal trial evaluating its AltaValve system. ATLAS (a transseptal left atrial system for the treatment of...

Procept Biorobotics wins FDA nod to study surgical robot for treating prostate cancer

The FDA approved an investigational device exemption (IDE) trial for Procept BioRobotics' Aquablation therapy. The WATER IV PCa trial will compare Aquablation to radical...

Perimeter completes enrolment for AI-assisted breast imaging trial

Perimeter Medical Imaging AI has completed enrolment for the pivotal trial of its AI-assisted imaging technology, the Perimeter B-Series OCT system, for performing breast-conserving...

PARKEO2 clinical trial reaches key enrolment milestone ahead of schedule

RebrAIn, a leader in precise targeting solutions for deep brain stimulation (DBS) and lesion techniques, announced the successful early completion of recruitment for the...

Latest articles